CVS Health reported $415.1B of revenue over the trailing twelve months, +7.4% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $415.1B (to Q2 2026). Net income: $4.89B, trailing twelve months to Q2 2026. Free cash flow: $11.8B, trailing twelve months to Q2 2026. Operating margin: 2.0%, trailing twelve months to Q2 2026.

CVSCVS Health

Healthcare

$86.18+19% 1Y

$86.18

$69.4752 weeks$110.58

Latest close: back above its 200-day averageOct 9, 2026what changed →

CVS as reported

CVS Health reported $415.1B of revenue over the trailing twelve months, +7.4% on the year before. 11 reported series are charted on this page, each one as filed.

$415.1B

Revenue, trailing twelve months · to Q2 2026 · +7.4% against the twelve months before

Net income: $4.89B
Net income · +7.9% year on year · trailing twelve months to Q2 2026
Free cash flow: $11.8B
Free cash flow · +146% year on year · trailing twelve months to Q2 2026
Operating margin: 2.0%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CVS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$415.1B	+7.4%	Q2 2026
Net income	$4.89B	+7.9%	Q2 2026
EPS	$3.80	+5.8%	Q2 2026
Gross margin	44%	n/a	Q2 2026
Operating margin	2.0%	n/a	Q2 2026
Net margin	1.2%	n/a	Q2 2026
ROE	3.2%	n/a	Q2 2026
ROA	0.99%	n/a	Q2 2026
ROIC	3.7%	n/a	Q2 2026
Free cash flow	$11.8B	+146%	Q2 2026
P/E	22.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.